Increased plasma carnitine concentrations in preeclampsia

Obstetrics and Gynecology

Volumn 103, Issue 5 I, 2004, Pages 876-880

  Thiele, Ingrit G I ^b   Niezen Koning, Klary E ^b   Van Gennip, Albert H ^b   Aarnoudse, Jan G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARNITINE; LIPID; FATTY ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; FETUS DEATH; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOPATHOLOGY; KIDNEY DYSFUNCTION; LIPID BLOOD LEVEL; LIPID METABOLISM; METABOLIC REGULATION; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; BLOOD; COMPARATIVE STUDY; METABOLISM; OXIDATION REDUCTION REACTION; PREGNANCY;

CARNITINE; FATTY ACIDS; FEMALE; HUMANS; OXIDATION-REDUCTION; PRE-ECLAMPSIA; PREGNANCY;

EID: 2942746315     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000125699.60416.03     Document Type: Article

References (27)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
2. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001;357:53-6
3. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222:222-35.
4. Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol 1996;103: 614-20.
5. Chappel LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999;354:810-6.
6. Ibdah JA, Benett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340: 1723-31.
7. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359-72.
8. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response: a review. Placenta 2003;24 suppl:S21-7.
9. Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta 2002;23:447-50.
10. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab 2003;284:E1098-105.
11. Rinaldo P, Matern D. Fatty acid oxidation disorders. Annu Rev Physiol 2002;64:477-502.
12. Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 2002;361:417-29.
13. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 2003;41 suppl:S4-12.
14. Bargen-Lockner C, Hahn P, Wittmann B. Plasma carnitine in pregnancy. Am J Obstet Gynecol 1981;140:412-4.
15. Cederblad G, Fahraeus L, Lindgren K. Plasma carnitine and renal-carnitine clearance during pregnancy. Am J Clin Nutr 1986;44:379-83.
16. Winter SC, Linn LS, Helton E. Plasma carnitine concentrations in pregnancy, cord blood, and neonates and children. Clin Chim Acta 1995;243:87-93.
17. Koumantakis E, Sifakis S, Koumantaki Y, Hassan E, Matalliotakis I, Papadopoulou E, et al. Plasma carnitine levels of pregnant adolescents in labor. J Pediatr Adolesc Gynecol 2001;14:65-9.
18. Vreken P, van Lint AEM, Bootsma AH, Overmars H, Wanders RJA, van Gennip AH. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects. J Inherit Metab Dis 1999;22:302-6.
19. Wang Y, Ye J, Ganapathy V, Longo N. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci U S A 1999;96:2356-60.
20. Schmidt-Sommerfeld E, Penn D, Wolf H. The influence of maternal fat metabolism on fetal carnitine levels. Early Hum Dev 1981;5:233-42.
21. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 1998;19:581-6.
22. Aardema MW, Oosterhof H, Timmer A, van Rooy I, Aarnoudse JG. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta 2001;22:405-11.
23. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000;14:1289-96.
24. Staff AC, Ranheim T, Khoury J, Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 1999;180:587-92.
25. Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998;178: 603-8.
26. Meyburg J, Schulze A, Kohlmueller D, Linderkamp O, Mayatepek E. Postnatal changes in neonatal acylcarnitine profile. Pediatr Res 2001;49:125-9.
27. Hayashi M, Ueda Y, Hoshimoto K, Ota Y, Fukasawa I, Sumori K, et al. Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia. Am J Kidney Dis 2002;39:392-400.